ACRS: Aclaris Therapeutics Inc. Sotuvga nisbatan narx

Aclaris Therapeutics Inc. (ACRS) kompaniyasining korporativ logotipi

Klinik muvaffaqiyatsizlik xatarlari va patent nizolari Aclaris Therapeutics (ACRS) kompaniyasiga salbiy ta'sir ko'rsatmoqda. Biroq, intellektual mulk litsenziyalash strategiyasi xarajatlarni minimallashtirib, erkin pul oqimi o'sishi uchun asos yaratmoqda. P/S koeffitsiyenti tendentsiyasi ushbu muvozanatni tasdiqlaydi va ushbu ko'rsatkich 91.90 ga yetdi. Gipertrofik immun patologiyalarini nishonga olgan kichik molekulalar portfeli ushbu samaradorlikni yanada tasdiqlaydi.

P/S multiplikatori: Aclaris Therapeutics, Inc. (ACRS) 04.07.2022 - 16.11.2026 uchun

Aclaris Therapeutics, Inc (ACRS) kompaniyasining tahliliy kesimlari

Kompaniyaning fundamental tahlili:Aclaris Therapeutics, Inc., ACRS
Aclaris tovar namunasi

Aclaris Therapeutics kompaniyasining uzoq muddatli terapevtik effektga ega immunologik dori vositalarini ishlab chiqishi kelajakdagi barqaror pul oqimlari uchun asos yaratadi. Narx-savdo koeffitsiyenti orqali aks etgan bozor qiymati va savdo hajmi o'rtasidagi bog'liqlik xarajatlar oshishi natijasidagi inflyatsiyaning marjalarga qanday ta'sir qilishini baholash imkonini beradi hamda fundamental o'sishni spekulyatsiyadan ajratishga yordam berib, aktivni baholash cho'qqisida sotib olishning oldini oladi.

Raqobatdosh kompaniyalar

argenx - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (biontech.de)|Abivax Corp (ABVX) - Sotuvga nisbatan narx|ADMA Corp - P/S multiplikatori|Narxning sotuvga nisbati PTGX|Immunovant Inc (IMVT) - Narxning daromadga nisbati|KNSA - Narx/daromad koeffitsiyenti|GRFS (Grifols Biemat) - P/S multiplikatori|P/S multiplikatori Adaptive Biotechnologies Inc.|Narxning daromadga nisbati Celldex Therapeutics (CLDX)|Narx/daromad koeffitsiyenti auriniapharma.com|Narxning daromadga nisbati BioCryst Pharmaceuticals BCRX|Bozor kapitallashuvining daromadga nisbati VERA|Dianthus Pharma - P/S multiplikatori|PHVS - P/S multiplikatori|ABCL: P/S multiplikatori|TRML (Tourmaline Bio, Inc.) - Narxning daromadga nisbati|Narxning daromadga nisbati Intrexon|PHAR - Narx/daromad multiplikatori|P/S multiplikatori NKTR|Narxning daromadga nisbati UPB (Upstream Bio Corp)|Narxning daromadga nisbati Zenas Biopharma, Inc. ZBIO|Narx/daromad koeffitsiyenti immunome.com (IMNM)|Gossamer Bio Inc - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati KALV (KalVista Pharmaceuticals, Inc.)|SEPN: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Pieris Pharmaceuticals Inc|Kapitalizatsiyaning daromadga nisbati SVRA|Kapitalizatsiyaning daromadga nisbati Rigel Pharmaceuticals (RIGL)|P/S multiplikatori ANAB|ATXS - Sotuvga nisbatan narx|Narxning daromadga nisbati enGene Corp ENGN|Narx/daromad koeffitsiyenti RAPT Therapeutics, Inc. (RAPT)|Aerovate - P/S multiplikatori|KYTX - P/S multiplikatori|TLSA: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Cabaletta Bio, Inc|Narxning daromadga nisbati Ventyx Biosciences, Inc|THTX: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati AVTX (Avalo Therapeutics, Inc)|Kapitalizatsiyaning daromadga nisbati Eledon Pharmaceuticals ELDN|Narxning daromadga nisbati Agenus, Inc. AGEN|P/S multiplikatori Climb Bio Inc. CLYM|ZURA - Narxning daromadga nisbati|Narxning sotuvga nisbati ATYR|ADAG (Adagene Inc.) - Kapitalizatsiyaning daromadga nisbati|ImageneBio Inc (IMA) - P/S multiplikatori|Narxning daromadga nisbati Shattuck Therapeutics|Kapitalizatsiyaning daromadga nisbati equilliumbio.com (EQ)|P/S multiplikatori CNTB|Narx/daromad koeffitsiyenti Immunic Therapeutics|P/S multiplikatori ATRA (Atara Biotherapeutics, Inc.)|IFRX - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati X4 Pharmaceuticals, Inc. (XFOR)|ACET (adicetbio.com) - Kapitalizatsiya va daromad nisbati|CELU: P/S multiplikatori|INMB - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Barinthus Biotherapeutics plc|KZR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori SABS|AKTX (Akari Therapeutics Plc) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ENLV (Enlivex Therapeutics Ltd)|q32bio.com - Narxning daromadga nisbati|GOVX: Kapitalizatsiyaning daromadga nisbati|edesabiotech.com (EDSA) - Kapitalizatsiyaning daromadga nisbati|IBIO: P/S multiplikatori|CARM - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati XTLB|Kapitalizatsiyaning daromadga nisbati boltbio.com (BOLT)|Narxning daromadga nisbati HCW Biologics Inc (HCWB)|P/S multiplikatori Aptevo Therapeutics, Inc. (APVO)|Narxning daromadga nisbati aimimmuno.com AIM|Bozor kapitallashuvining daromadga nisbati ADTX|GRI Bio Corporation - P/S multiplikatori|XORTX Corp (XRTX) - Kapitalizatsiyaning daromadga nisbati|HIND (Vyome Holdings Inc.) - Kapitalizatsiyaning daromadga nisbati|revbiosciences.com (REVB) - P/S multiplikatori|INDP (Indaptus Corp) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Scinai Immunotherapeutics Ltd (SCNI)|Narxning daromadga nisbati CalciMedica Inc (CALI)|AFMD (Affimed NV) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ALLK (Allakos Inc.)|P/S multiplikatori HOOKIPA HOOK|IGMS: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ITOS (iTeos)|OCEA: P/S multiplikatori|TCBP (TC BioPharm Ltd) - Narxning daromadga nisbati|THRD (Third Harmonic Bio Inc) - P/S multiplikatori